Ronald Knickerbocker
Corporate Officer/Principal at THESEUS PHARMACEUTICALS, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Bradford Dahms | M | 36 | 3 years | |
| Douglas Lankler | M | 58 | 25 years | |
| David C. Dalgarno | M | 66 | 7 years | |
| Christen Baglaneas | F | - | - | |
| Suneet Varma | M | 55 | 23 years | |
| Kristine Callahan | F | - | 3 years | |
| Victor Rivera | M | 59 | 7 years | |
| Wei-Sheng Huang | M | - | 7 years | |
| Mike McDermott | M | 58 | 21 years | |
| Katie Dahlstrom | F | - | - | |
| Leonard Rozamus | M | - | - | |
| Benjamin Enerson | M | - | - | |
| Shouryadeep Srivastava | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jeffrey Kindler | M | 68 | 8 years | |
| Henry McKinnell | M | 81 | 8 years | |
| Henri A. Termeer | M | 78 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 28 years |
| George A. Lorch | M | 82 | 15 years | |
| Christopher Viehbacher | M | 64 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Richard F. Syron | M | 80 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Alan Smith | M | 78 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 22 years |
| Peter Wirth | M | 73 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 years |
| Henry E. Blair | M | 80 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 26 years |
| Ralph Victor Whitworth | M | 68 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| William Sibold | M | 57 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Jonathan Emms | M | - | 20 years | |
| Olivier Brandicourt | M | 68 | 13 years | |
| Linda Bain | F | 53 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 3 years |
| Everett Cunningham | M | 57 | 9 years | |
| Paul Fitzhenry | M | 64 | 4 years | |
| Roger W. Louis | M | 69 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 years |
| Gloria Matthews | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 6 years |
| George Milne | M | 80 | 32 years | |
| Peter Corr | M | 76 | 6 years | |
| Michael R. Jirousek | M | 65 | 5 years | |
| Alexandra Kropotova | M | 51 | 5 years | |
| Michael Wyzga | M | 69 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 13 years |
| Brian Schiller | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 10 years |
| Steven J. Burakoff | M | 81 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Robert N. Burt | M | 86 | 11 years | |
| Julie Feder | F | 54 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| William Herbert Gray | M | 82 | 13 years | |
| John Thompson | M | 57 | 7 years | |
| Howard Mayer | M | 61 | 7 years | |
| Hakan Sakul | M | - | 22 years | |
| Jeroen van Beek | M | - | 8 years | |
| Craig M. Audet | M | 59 | 5 years | |
| Krishan K. Arora | M | 83 | 5 years | |
| Rodney Lappe | M | 69 | 7 years | |
| Dan Garofalo | M | 48 | 4 years | |
| Ravi Kiron | M | 64 | 13 years | |
| Anja Guntermann | M | - | 9 years | |
| Anna Levander | F | 47 | 3 years | |
| Howard Welgus | M | 72 | 10 years | |
| Julia Stephanus | F | 65 | 14 years | |
| Yugal Kishor C. Sikri | M | 66 | 6 years | |
| Glenn David | M | 52 | 14 years | |
| Chen Xiang Yang | M | 58 | 11 years | |
| Hugo Mendoza | M | - | 8 years | |
| Joann Eisenhart | M | 65 | 12 years | |
| Matthew Rossen | M | 47 | 9 years | |
| William Pringle | M | 56 | 6 years | |
| Lee Golden | M | 56 | 4 years | |
| Andy Schmeltz | M | - | 20 years | |
| Viviane Monges | F | 60 | 5 years | |
| Paul M. Villani | M | 58 | 6 years | |
| Eduardo Von Pervieux | M | - | 6 years | |
| Michael T. Sweeney | M | 63 | 8 years | |
| Francesco Granata | M | 73 | 2 years | |
| John LaMattina | M | 74 | 4 years | |
| Victor Micati | M | 83 | 34 years | |
| John W. Poyhonen | M | 64 | 7 years | |
| James L. Freddo | M | 69 | 3 years | |
| Peter Powchik | M | 67 | 5 years | |
| Karin Ludwig | M | - | - | |
| Robert E. Grasty | M | 55 | - | |
| Lance Berman | M | 53 | 6 years | |
| Philip D. Worboys | M | 54 | 2 years | |
| Patricia L. Burmahl | F | 62 | 4 years | |
| John F. Niblack | M | 85 | 35 years | |
| Wendell Wierenga | M | 76 | 10 years | |
| Steven Romano | M | 64 | 16 years | |
| Craig Saxton | M | 81 | 25 years | |
| Robert Zerbe | M | 73 | 7 years | |
| Brian R. Krause | M | - | - | |
| Alexander Polinsky | M | 67 | 8 years | |
| James New | M | 70 | 5 years | |
| Mark W. Pierce | M | 75 | 3 years | |
| Frank Sciavolino | M | 83 | 35 years | |
| Julie A. Olson | M | - | 19 years | |
| Gill Eapen | M | - | 3 years | |
| Yoshihiro Toyohara | M | - | 2 years | |
| Gerard G. Gorman | M | 73 | 5 years | |
| Bill Burkoth | M | 47 | - | |
| Arthur Peter Bertolino | M | 69 | 4 years | |
| Sep Sarshar | M | 57 | 3 years | |
| Kathleen Boziwick | F | - | - | |
| Nicholas Lee Gurreri | M | - | 4 years | |
| Thomas G. Gant | M | - | 6 years | |
| Ngozi Edozien | F | 59 | 6 years | |
| Michelle Nasir | F | - | 6 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ronald Knickerbocker
- Personal Network
